https://www.selleckchem.com/pr....oducts/gsk650394.htm
Providing high-risk youth with strategies to enhance symptom self-management may result in decreased symptom prevalence, improved quality of life, and long-term reduction of cardiovascular morbidity and mortality as they move into adulthood. Moreover, developing low-cost, scalable tools with end-user input may facilitate promote early intervention and improved access to care, and reduce overall disease burden and healthcare costs.Sedentariness of patients affected by end-stage kidney disease (ESKD) expose them to high risk of unfavora
Aimer
Commentaire
Partagez
